EOFLOW Co., Ltd. (KOSDAQ:294090)
South Korea · Delayed Price · Currency is KRW 1,490.00
-89.00 (-5.64%)
Mar 21, 2025, 5:10 PM KST
EOFLOW Revenue
EOFLOW had revenue of 124.20M KRW in the quarter ending June 30, 2026, a decrease of -86.60%. This brings the company's revenue in the last twelve months to 2.00B, down -50.27% year-over-year. In the year 2025, EOFLOW had annual revenue of 3.67B, down -29.99%.
Revenue (ttm)
2.00B
Revenue Growth
-50.27%
P/S Ratio
25.62
Revenue / Employee
n/a
Employees
n/a
Market Cap
51.11B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.67B | -1.57B | -29.99% |
| Dec 31, 2024 | 5.24B | -1.35B | -20.45% |
| Dec 31, 2023 | 6.59B | -118.66M | -1.77% |
| Dec 31, 2022 | 6.71B | 6.01B | 867.57% |
| Dec 31, 2021 | 693.27M | 671.61M | 3,101.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| DRTECH | 126.23B |
| Ray Co., Ltd. | 119.17B |
| Osang Healthcare Co.,Ltd | 96.48B |
| LabGenomics | 77.64B |
| Humasis | 31.73B |
| Access Bio | 23.54B |
| HASS Corp. | 16.08B |
| Sugentech | 9.78B |
EOFLOW News
- 5 weeks ago - EOFLOW Quarterly report: Q2 2026 - Filings
- 4 months ago - EOFLOW Quarterly report: Q1 2026 - Filings
- 5 months ago - EOFLOW Annual report: Q4 2025 - Filings
- 5 months ago - EOFLOW Quarterly report: Q4 2025 - Filings
- 10 months ago - EOFLOW Quarterly report: Q3 2025 - Filings